Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review

Enochian Biosciences' Cancer Platform on Track for Human Trials by 2024 Enochian Biosciences has announced that its innovative Cancer Platform is expected to undergo clinical trials in humans during the first half of 2024. The US Food and Drug Administration (FDA) recently confirmed this after reviewing Enochian's Pre-Investigational New Drug Application submission. The company’s technology uses..